Wuxi Weitere Pharmaceutical Co., Ltd.
Adresse: Huishan Life Science and Technology Industrial Park, Bezirk Huishan, Wuxi, China
WhatsApp: + 86 18036885286; E-Mail: wuxifurther@gmail.com
Lenmeldy – das derzeit teuerste Medikament der Welt
Worldwide, the therapeutics market is already flooded with therapies that cost more than $1 million per dose. At least 10 drugs (As following table ) have reached this milestone, mainly gene therapies, but also small molecule drug modalities. Recently, the one-time gene therapy Lenmeldy for early-onset metachromatic leukodystrophy (MLD) of Orchard Therapeutics has been approved by the FDA for sale, priced at $4.25 million, raising the price of the world's most expensive drug by 21%.
Arzneimittelname | Preis/Dosis (Millionen $) | Indikationen | Hersteller | Genehmigungszeit | Therapiemethoden | |
Lenmeldy | 4.25 | Metachromatische Leukodystrophie (MLD) | Orchard Therapeutics | 2024.3.18 | Gentherapie | |
Hemgenix | 3.50 | Hämophilie B | CSL Behring and uniQure | 2022.11.22 | Gentherapie | |
Skysona | 3.00 | CALD | Bluebird-Biografie | 2022.9.18 | Gentherapie | |
Zynteglo | 2.80 | β-Thalassämie | Bluebird-Biografie | 2022.8.17 | Gentherapie | |
Zolgensma | 2.10 | SMA | Nuohua | 2019.5.26 | Gentherapie | |
Lamzede | 1.46 | Alpha-Mannosid-Speichersyndrom | Chiesi | 2023.2.16 | Enzymersatztherapie | |
Myalept | 1.26 | Systemische Lipodystrophie | Chiesi Pharmaceutici | 2014.2.25 | Protein | |
Sohonos | 1.40 | GECK | Ipsen | 2023.8.16 | Mikromolekül | |
Zokinvy |
1.00 | Hutchinson-Gilford | EigerBioPharmaceuticals | 2020.11.20 | Mikromolekül | |
Daniela | 1.00 | Refraktäres Neuroblastom im Knochen oder Knochenmark | Y-mAbs Therapeutics | 2020.11.25 | McAb (monoklonaler Antikörper) |